Delisting risk
CMND · NASDAQ · Biotechnology

Clearmind Medicine (CMND)

Develops non-hallucinogenic MEAI treatments for alcohol use disorder and related conditions.

$1.75
Pre-market−0.11 (−6.11%)
At close$1.86(+1.64%)

Something off on this page? Send us feedback.

EPSReportedEstimate

Sep '24Jan '25Mar '25Jun '25Sep '25Jan '26Mar '26Jun '26
Reported−$0.59−$0.11−$9.60−$6.40−$10.00−$4.40−$3.32−$6.78
Estimate
Surprise

RevenueReportedEstimate

Sep '24Jan '25Mar '25Jun '25Sep '25Jan '26Mar '26Jun '26
Reported
Estimate
Surprise

History

DateEstimateReportedSurprise
Jun 2026−$6.78
Jun 2026
Mar 2026−$3.32
Jan 2026−$4.40
Sep 2025−$10.00

The latest year is open to everyone — the 31 quarters behind it read with an account.

Sign in
Jun 2025
Mar 2025
Jan 2025
Sep 2024
Jun 2024
Mar 2024
Jan 2024
Sep 2023
Jun 2023
Mar 2023
Feb 2023
Jul 2022
Apr 2022
Jan 2022
Oct 2021
Jul 2021
Apr 2021
Jan 2021
Oct 2020
Jul 2020
Apr 2020
Jan 2020
Oct 2019
Jul 2019
Apr 2019
Jan 2019
Oct 2018
Jul 2018
Apr 2018
Jan 2018
Oct 2017
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Jun 15, 2026−$6.78−6.8%
Jun 11, 2026
Mar 12, 2026−$3.32−5.9%
Jan 28, 2026−$4.40−13.1%
Sep 11, 2025−$10.00−2.9%

The latest year is open to everyone — the 31 quarters behind it read with an account.

Sign in
Jun 12, 2025
Mar 13, 2025
Jan 22, 2025
Sep 16, 2024
Jun 13, 2024
Mar 18, 2024
Jan 29, 2024
Sep 13, 2023
Jun 14, 2023
Mar 17, 2023
Feb 3, 2023
Jul 31, 2022
Apr 30, 2022
Jan 31, 2022
Oct 31, 2021
Jul 31, 2021
Apr 30, 2021
Jan 31, 2021
Oct 31, 2020
Jul 31, 2020
Apr 30, 2020
Jan 31, 2020
Oct 31, 2019
Jul 31, 2019
Apr 30, 2019
Jan 31, 2019
Oct 31, 2018
Jul 31, 2018
Apr 30, 2018
Jan 31, 2018
Oct 31, 2017